Tissue Factor Expression in Obese Type 2 Diabetic Subjects and Its Regulation by Antidiabetic Agents
Objective. Increased coagulation activation may contribute to the high incidence of cardiovascular complications observed in obese and type 2 diabetes (T2D) subjects. Although tissue factor (TF), the primary initiator of coagulation is increased in obesity, its expression in adipose tissues and its...
Main Authors: | Jing Wang, Theodore P. Ciaraldi, Fahumiya Samad |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | Journal of Obesity |
Online Access: | http://dx.doi.org/10.1155/2015/291209 |
Similar Items
-
Myokine Regulation of Insulin Secretion: Impact of Inflammation and Type 2 Diabetes
by: Alexander J. Ryan, et al.
Published: (2020-01-01) -
Profiles of Antidiabetic Agents and Dosage Adjustments in Association with Glycemic Control in Diabetic Subjects
by: Hsiu-Chu Chen, et al.
Published: (2005) -
The Impact of Antidiabetic Agents on Sarcopenia in Type 2 Diabetes: A Literature Review
by: Chen-Ning Wu, et al.
Published: (2020-01-01) -
Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents
by: Babiker Saad Almugadam, et al.
Published: (2020-01-01) -
Dose modification of antidiabetic agents in patients with type 2 diabetes mellitus and heart failure
by: D C Sharma, et al.
Published: (2017-01-01)